Assay / Immunoassay

Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders

Affimer-based research assay launched alongside performance data published by Bruker

Test kits on the market vary drastically in their limits of detection

This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus

ImmunoRank offers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins

Study finds that glial fibrillary acidic protein levels in the blood can predict intracranial abnormalities on CT scans in patients with traumatic brain injury

Inconsistencies among vitamin D testing methods highlight the need for standardization across labs